Feb 23 2025 2 mins 6
A San Antonio researcher is working on a drug that could treat Ewing sarcoma and rhabdomyosarcoma without lifelong side effects. It would be the first new treatment option for these childhood cancers in 30 years.
Science & Medicine: Sabotaging the molecular engines of some pediatric cancers
1.0x
00:00
00:00
